BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Gilead Sciences, Inc.'s Single Tablet HIV Regimen Meets Goals In Two Phase 3 Studies     9/25/2014
GlaxoSmithKline-Pfizer Inc.'s ViiV Healthcare Wins Approval For HIV Combo Drug     8/25/2014
New Jersey's Immune Response BioPharma, Inc. Unveils Plans To Develop In House Sales Force For HIV Blockbuster Remune     8/7/2014
CytoDyn Announces Positive Interim Results From Its Treatment Substitution Study in Patients With HIV     7/31/2014
Study Claims Celgene Drug Can Drive HIV Out Of Hiding     7/25/2014
ViiV Healthcare: HIV Combo Therapy Candidate Fails Phase 3     7/23/2014
GlaxoSmithKline's ViiV Healthcare Joins Johnson & Johnson's Janssen Research & Development To Develop Single-Pill HIV Drug     6/12/2014
FDA Accepts Gilead Sciences, Inc.'s Two NDAs For HIV Therapy     4/22/2014
GlaxoSmithKline's ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool     4/2/2014
Merck & Co., Inc. HIV Drug Strategy Seen Shielding Patent     3/21/2014
Bay Area's Sangamo BioSciences, Inc. Surges As Gene Editing Tech Make Cells Repel HIV     3/6/2014
Merck & Co., Inc.'s Investigational Hepatitis C Drugs Work In HIV Co-Infected Patients In Phase 2 Study     3/6/2014
AbbVie AIDS Drug Clears Pre-Cancerous Lesions In Kenyan Study     2/18/2014
European Commission (EC) Approves Gilead Sciences, Inc.'s Vitekta™, To Treat HIV-1 Infection     11/18/2013
FDA Approves GlaxoSmithKline's HIV Drug     8/14/2013
 Featured Stories
2nd Baby Cured Of HIV Relapses, Lancet Reveals     10/3/2014
Teen’s Organs Rejected Because He’s Gay     8/18/2014
Two Cancer Patients "Cured" Of AIDS After Bone Marrow Transplants, St. Vincent Hospital Study     7/21/2014
Joep Lange, The Physician-Scientist Before Medical Diplomat     7/21/2014
Top AIDS Researchers Killed In Malaysia Airlines Crash, Renowned Scientist Joep Lange Among Dead     7/21/2014
AIDS Epidemic May Be Over By 2030 – United Nations Reveals     7/17/2014
Evidence Reveals The Baby That Was "Cured" Of HIV Wasn't     7/11/2014
Egyptian Military Backtracks On Aids Cure Claims     7/2/2014
New AIDS Monkey Model Offers Promise For Medical Research, Rockefeller University Study     6/23/2014
At Risk Of HIV? Pop A Pill For Protection, Says Centers for Disease Control and Prevention (CDC)     5/23/2014
Soy Sauce Compound May Unlock Drug Therapy For HIV Patients, University of Missouri Researcher Finds     5/7/2014
Experimental Drug Prolongs Life Span In Mice, and Northwestern University and Tohoku University Study     5/5/2014
Man Who Co-Discovered HIV Reveals Why There Won’t Be A Cure For AIDS     4/25/2014
Transplant Drugs May Help Wipe Out Persistent HIV Infections, University of California, San Francisco (UCSF) Study     4/3/2014
Good Bacteria That Protects Against HIV Identified, University Of Texas Medical Branch At Galveston Study     3/31/2014
 More News
ViiV Healthcare Expands Program To Reduce HIV Disparities In Southern U.S.     10/20/2014
Sangamo BioSciences, Inc. (SGMO) ZFP Therapeutic Program In HIV/AIDS Featured At Three Major Scientific Conferences In October 2014     10/16/2014
ViiV Healthcare Receives Approval For Triumeq™ (dolutegravir/abacavir/lamivudine), In Canada - A New Once-Daily Single-Pill Regimen For The Treatment Of HIV     10/14/2014
CytoDyn Announces 100% Success With PRO 140 In Four-Week Monotherapy Clinical Trial     10/13/2014
CytoDyn Announces Investment Community Call To Discuss Results From Its Treatment Substitution Clinical Trial In Patients With HIV     10/13/2014
Caprion Pharmaceuticals Highlights Recently Published Data On Strengthening Immune Response In HIV Utilizing CD160 And PD1-Targeted Antibodies     10/9/2014
Immunotech Laboratories Updates Progress On Negotiations For Phase 3 Testing On Its Treatments For HIV/AIDS And Hepatitis C Viruses In Macedonia And Serbia     10/7/2014
Mylan Inc. (MYL) Launches Generic Combivir®     10/6/2014
CEL-SCI (CVM) & U.S. Navy Administer Multikine To First Volunteer Patient In Phase I Clinical Trial For Treatment Of Anal Warts In HIV/HPV Co-Infected Patients     9/29/2014
Janssen-Cilag International NV (JNJ) Release: CHMP Announces Positive Opinion For REZOLSTA™, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat     9/29/2014
Roche (RHHBY) Launches Global Access Program For HIV Viral Load Testing     9/26/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV     9/17/2014
American Academy of HIV Medicine Release: Olympian Greg Louganis Shares Personal Experience On Aging With HIV Exclusively On HIV-Age.Org     9/17/2014
New York Blood Center Receives $2 Million In NIDA Funding To Develop HIV Self-Testing Intervention     9/16/2014
PhRMA Release: New Medicines In Development Give Hope To Patients With HIV/AIDS     9/10/2014